The poor prognosis of NSCLC cases with HER2 and KRT19 overexpression as identified using publicly available databases further strengthened our findings of the cooperative effect of HER2 and KRT19 on malignant behavior in double-positive lung cancers. Here, ERBB2 is linked to non-small cell lung carcinoma.